M3 (TSE:2413) Gross-Profit-to-Asset %

: 32.90% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. M3's annualized Gross Profit for the quarter that ended in Dec. 2023 was 円152,160 Mil. M3's average Total Assets over the quarter that ended in Dec. 2023 was 円462,429 Mil. Therefore, M3's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 32.90%.

M3 Gross-Profit-to-Asset % Historical Data

The historical data trend for M3's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M3 Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

50.32

40.59

41.78

39.82

36.21

M3 Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															39.79	33.00	32.98	30.37	32.90

Competitive Comparison

For the Health Information Services subindustry, M3's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

M3 Gross-Profit-to-Asset % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, M3's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where M3's Gross-Profit-to-Asset % falls into.

M3 Gross-Profit-to-Asset % Calculation

M3's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2023 )	/	( (Total Assets (A: Mar. 2022 )	+	Total Assets (A: Mar. 2023 ))	/ count )
	=	135186	/	( (345981	+	400645)	/ 2 )
	=	135186	/	373313
	=	36.21 %

M3's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	152160	/	( (461018	+	463840)	/ 2 )
	=	152160	/	462429
	=	32.90 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

M3 Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of M3's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

M3 (TSE:2413) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M3 Inc (TSE:2413) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

MTHRY:USA MTHRF:USA 4YC:Germany

Address

Akasaka Intercity 10th floor, 1-11-44 Akasaka, Minato-ku, Tokyo, JPN, 105-0012

Website

http://corporate.m3.com

M3, Inc. is a Japan-based company engaged in providing medical-related services through the use of the Internet. It also supports marketing of pharmaceutical companies and medical equipment manufacturers. The company's business segment includes, Medical Portal segment, Evidence Solution segment, Overseas segment, Clinical Platform segment, Sales Platform segment, and Others. The company generates the majority of its revenue from Medical Portal segment.

M3 (TSE:2413) Headlines

No Headlines